Equillium, Inc. (EQ)
1.27
-0.15
(-10.56%)
USD |
NASDAQ |
Oct 22, 16:00
1.26
-0.01
(-0.79%)
After-Hours: 20:00
Equillium Net Income (Quarterly) : -4.693M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.693M |
| March 31, 2026 | -5.311M |
| December 31, 2025 | -3.775M |
| September 30, 2025 | -4.23M |
| June 30, 2025 | -5.739M |
| March 31, 2025 | -8.654M |
| December 31, 2024 | -5.794M |
| September 30, 2024 | -0.007M |
| June 30, 2024 | 0.468M |
| March 31, 2024 | -2.734M |
| December 31, 2023 | -2.342M |
| September 30, 2023 | -3.71M |
| June 30, 2023 | -3.343M |
| March 31, 2023 | -3.94M |
| December 31, 2022 | 2.773M |
| September 30, 2022 | -13.66M |
| June 30, 2022 | -14.13M |
| Date | Value |
|---|---|
| March 31, 2022 | -37.42M |
| December 31, 2021 | -10.62M |
| September 30, 2021 | -10.28M |
| June 30, 2021 | -9.158M |
| March 31, 2021 | -8.991M |
| December 31, 2020 | -8.918M |
| September 30, 2020 | -6.597M |
| June 30, 2020 | -6.461M |
| March 31, 2020 | -7.837M |
| December 31, 2019 | -7.567M |
| September 30, 2019 | -6.014M |
| June 30, 2019 | -6.069M |
| March 31, 2019 | -5.95M |
| December 31, 2018 | -4.992M |
| September 30, 2018 | -4.916M |
| March 31, 2018 | -1.577M |
| September 30, 2017 | -0.141M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Anika Therapeutics, Inc. | 3.309M |
| Savara, Inc. | -40.23M |
| Vericel Corp. | 2.206M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 4.693M |
| EPS Diluted (Quarterly) | -0.042 |
| Enterprise Value | 23.95M |
| Earnings Yield | -15.99% |
| Normalized Earnings Yield | -15.98 |